Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

PHASE4CompletedINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Bladder CancerCervical CancerEsophageal CancerGastric CancerHead and Neck CancerKidney CancerLeukemiaLiver CancerLung CancerPancreatic CancerTobacco Use Disorder
Interventions
BEHAVIORAL

smoking cessation intervention

DRUG

bupropion hydrochloride

GENETIC

gene expression analysis

GENETIC

polymerase chain reaction

OTHER

counseling intervention

OTHER

educational intervention

PROCEDURE

psychosocial assessment and care

Trial Locations (2)

64130

Swope Health Central, Kansas City

66160-7357

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Lisa Sanderson Cox, PhD

OTHER

NCT00666978 - Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | Biotech Hunter | Biotech Hunter